BIOVF - Swedish Orphan Biovitrum AB (publ) (BIOVF) CEO Guido Oelkers on Q4 2020 Results - Earnings Call Transcript
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2020 Earnings Conference Call February 18, 2021, 07:00 ET Company Participants Guido Oelkers - CEO & President Ravi Rao - Head, Research & Development & Chief Medical Officer Henrik Stenqvist - CFO Conference Call Participants Christopher Uhde - SEB Peter Sehested - Handelsbanken Viktor Sundberg - ABG Sundal Collier Erik Hultgard - Carnegie Investment Bank Presentation Operator Ladies and gentlemen, welcome to the Sobi presentation. [Operator Instructions]. I will now hand over to Guido Oelkers, CEO. Please go ahead. Guido Oelkers Yes. Thank you so much, and welcome to the Q4 webcast of Sobi. As per usual, I go straight to the forward-looking statement, and we just take note of it, not going to read it through, but just be aware. Today, I'm going to be joined by my colleagues, Henrik Stenqvist, the CFO; and Ravi Rao, the Head of R&D. And with
For further details see:
Swedish Orphan Biovitrum AB (publ) (BIOVF) CEO Guido Oelkers on Q4 2020 Results - Earnings Call Transcript